Medical Marijuana Inc (MJNA)
US Market

Medical Marijuana (MJNA) Stock Price & Analysis


MJNA Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.01 - $0.03
Previous Close$0.01
Average Volume (3M)N/A
Market Cap
Enterprise Value$21.81M
Total Cash (Recent Filing)$3.27M
Total Debt (Recent Filing)$9.32M
Price to Earnings (P/E)-2.1
May 24, 2023
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding3,444,369,867
10 Day Avg. Volume4,985,890
30 Day Avg. VolumeN/A
Standard Deviation0.32
Financial Highlights & Ratios
Price to Book (P/B)0.32
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)99.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.42
Enterprise Value/Gross Profit1.18
Enterprise Value/Ebitda-0.07
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0




What was Medical Marijuana Inc’s price range in the past 12 months?
Medical Marijuana Inc lowest stock price was $0.01 and its highest was $0.03 in the past 12 months.
    What is Medical Marijuana Inc’s market cap?
    Currently, no data Available
    When is Medical Marijuana Inc’s upcoming earnings report date?
    Medical Marijuana Inc’s upcoming earnings report date is May 24, 2023 which is in 57 days.
      How were Medical Marijuana Inc’s earnings last quarter?
      Medical Marijuana Inc released its earnings results on Nov 22, 2022. The company reported -$0.001 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.001.
        Is Medical Marijuana Inc overvalued?
        According to Wall Street analysts Medical Marijuana Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does Medical Marijuana Inc pay dividends?
          Medical Marijuana Inc does not currently pay dividends.
          What is Medical Marijuana Inc’s EPS estimate?
          Medical Marijuana Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does Medical Marijuana Inc have?
          Medical Marijuana Inc has 3,846,669,400 shares outstanding.
            What happened to Medical Marijuana Inc’s price movement after its last earnings report?
            Medical Marijuana Inc reported an EPS of -$0.001 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of Medical Marijuana Inc?
              Among the largest hedge funds holding Medical Marijuana Inc’s share is Fisher Asset Management LLC. It holds Medical Marijuana Inc’s shares valued at N/A.


                Medical Marijuana Stock Smart Score

                Not Ranked


                Return on Equity
                Trailing 12-Months
                Asset Growth
                Trailing 12-Months
                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Medical Marijuana Inc

                Medical Marijuana, Inc. engages in the development, sale, and distribution of hemp oil that contains naturally occurring cannabinoids. It operates through the following three segments: U.S. Operations, HempMeds and Kannaway. The company's services include development of cannabinoid based health and wellness products, and the development of medical grade compounds. Its brands include Defined, Revive, Hempvap, Kannakick and Canchew. Medical Marijuana was founded in March 2009 and is headquartered in Poway, CA.


                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                ATI Physical Therapy
                Enzo Biochem
                Bitech Technologies Corporation

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis